✦ LIBER ✦

58 TREATMENT OF CHRONIC HEPATITIS C WITH TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON-ALFA-2A WITH OR WITHOUT RIBAVIRIN: FURTHER INTERIM ANALYSIS RESULTS OF THE PROVE2 STUDY

✍ Scribed by G.M. Dusheiko; C. Hezode; S. Pol; T. Goeser; J.-P. Bronowicki; M. Bourliere; P. Buggisch; L. Serfaty; T. Berg; P. Couzige; Y. Benhamou; N. Forestier; L. Bengtsson; S. Gharakhanian; R. Kauffman; J. Alam; P. Ferenci; J.-M. Pawlotsky; S. Zeuzem

Book ID: 117375984
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60060-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

160 Prove2 Study: Treatment of Chronic H

160 Prove2 Study: Treatment of Chronic Hepatitis C with Telaprevir (TVR)in Combination with Peginterferon-Alfa-2a with or Without Ribavirin, Interim Analysis Results

✍ Hezode, Christophe; Ferenci, Peter; Dusheiko, Geoffrey M.; Tran, Albert; Grange, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 96 KB

1363 VX-222 WITH TVR ALONE OR IN COMBINA

1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS

✍ Di Bisceglie, A.M.; Nelson, D.R.; Gane, E.; Alves, K.; Koziel, M.J.; De Souza, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 129 KB

4 PROVE1: RESULTS FROM A PHASE 2 STUDY O

4 PROVE1: RESULTS FROM A PHASE 2 STUDY OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH HEPATITIS C

✍ J.G. Mchutchison; G.T. Everson; S.C. Gordon; I. Jacobson; R. Kauffman; L. McNair 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

223 Prove1: Results from a Phase 2 Study

223 Prove1: Results from a Phase 2 Study of Telaprevir with Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Hepatitis C

✍ Everson, Gregory T.; Jacobson, Ira M.; Gordon, Stuart C.; McHutchison, John G.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Pharmacoeconomic analysis of the treatme

Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain

✍ Turnes, Juan; Romero-Gómez, Manuel; Planas, Ramón; Solà, Ricard; García-Samanieg 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 610 KB

50 ACTIVITY OF TELAPREVIR ALONE OR IN CO

50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB